| scholarly article | Q13442814 |
| P50 | author | Chutima Srimaroeng | Q59682064 |
| Douglas H Sweet | Q64658376 | ||
| P2093 | author name string | Adam L Vanwert | |
| P2860 | cites work | Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections. | Q54092908 |
| Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. | Q54767527 | ||
| Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes | Q68490484 | ||
| Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide | Q71809928 | ||
| Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carbo | Q72777181 | ||
| The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding | Q74730523 | ||
| Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates | Q24649482 | ||
| Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G | Q24649515 | ||
| Stoichiometry of organic anion/dicarboxylate exchange in membrane vesicles from rat renal cortex and hOAT1-expressing cells | Q28184081 | ||
| Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney | Q28576093 | ||
| The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. | Q30759685 | ||
| Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever | Q31140106 | ||
| Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) | Q33674911 | ||
| Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). | Q33789579 | ||
| Transport of cimetidine by flounder and human renal organic anion transporter 1. | Q34158797 | ||
| The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics | Q34468094 | ||
| Effect of probenecid on the distribution and elimination of ciprofloxacin in humans | Q34720221 | ||
| Microbiology of newer fluoroquinolones: focus on respiratory pathogens | Q35031124 | ||
| Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme | Q35059616 | ||
| Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity | Q35059655 | ||
| Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine | Q35570563 | ||
| Pharmacokinetics of ciprofloxacin after oral and parenteral administration | Q35570646 | ||
| The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3. | Q35699239 | ||
| US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax | Q35861305 | ||
| Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose | Q39078187 | ||
| Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. | Q39556815 | ||
| Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2. | Q40214433 | ||
| Transport of levofloxacin in the OK kidney epithelial cell line: interaction with p-aminohippurate transport | Q40790890 | ||
| Basolateral localization of organic cation transporter 2 in intact renal proximal tubules | Q40845981 | ||
| Localization of an organic anion transporter-GFP fusion construct (rROAT1-GFP) in intact proximal tubules | Q40949396 | ||
| Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes. | Q41220992 | ||
| Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans | Q42115623 | ||
| Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney | Q42667896 | ||
| Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys | Q43483696 | ||
| Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. | Q43993855 | ||
| Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient | Q44253313 | ||
| Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges | Q44667412 | ||
| Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition | Q44792818 | ||
| Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). | Q46249191 | ||
| A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters | Q46592194 | ||
| Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules | Q46774647 | ||
| Transepithelial transport of levofloxacin in the isolated perfused rat kidney. | Q50513045 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 122-131 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin | |
| P478 | volume | 74 |
| Q88601232 | A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life |
| Q42074505 | Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8). |
| Q45342443 | Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5. |
| Q34495464 | Antibiotic Treatment of Dogs and Cats during Pregnancy |
| Q35155913 | Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity |
| Q33668223 | Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid |
| Q37333151 | Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid |
| Q90254015 | Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters In Vitro |
| Q52955403 | Crystalline nephropathy caused by tosufloxacin. |
| Q38981520 | Cumulative organic anion transporter-mediated drug-drug interaction potential of multiple components in salvia miltiorrhiza (danshen) preparations |
| Q35128143 | Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury |
| Q88626358 | Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication |
| Q45111373 | Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. |
| Q44737065 | Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans |
| Q37995676 | Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters. |
| Q55514622 | Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition. |
| Q36265861 | Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure |
| Q37001887 | Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway |
| Q38094882 | Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials |
| Q49255352 | In vitro-in vivo studies of the quantitative effect of calcium, multivitamins and milk on single dose ciprofloxacin bioavailability. |
| Q41537511 | Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family |
| Q42278894 | Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy |
| Q39437374 | Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). |
| Q35579522 | Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2). |
| Q34886134 | Is Ciprofloxacin a Substrate of P-glycoprotein? |
| Q38685365 | Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes |
| Q35213248 | Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis |
| Q34243889 | Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6 |
| Q95795711 | Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach |
| Q33592687 | Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles |
| Q44183032 | Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers |
| Q38636236 | Pharmacokinetics of intravenous finafloxacin in healthy volunteers. |
| Q35122873 | Physiological and molecular characterization of aristolochic acid transport by the kidney |
| Q34117674 | Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8) |
| Q37278319 | Regulation of renal organic anion transporter 3 (SLC22A8) expression and function by the integrity of lipid raft domains and their associated cytoskeleton |
| Q39140289 | Renal Drug Transporters and Drug Interactions |
| Q36689589 | The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers |
| Q47198594 | The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease. |
| Q38648038 | The drug transporter OAT3 (SLC22A8) regulates endogenous metabolite flow through the gut-liver-kidney axis |
| Q42513426 | Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug |
| Q83466964 | Use of transgenic and knockout mouse models to assess solute carrier transporter function |
| Q33714593 | Xenobiotic, bile acid, and cholesterol transporters: function and regulation. |
Search more.